540 related articles for article (PubMed ID: 30400878)
1. A pan-cancer analysis of driver gene mutations, DNA methylation and gene expressions reveals that chromatin remodeling is a major mechanism inducing global changes in cancer epigenomes.
Youn A; Kim KI; Rabadan R; Tycko B; Shen Y; Wang S
BMC Med Genomics; 2018 Nov; 11(1):98. PubMed ID: 30400878
[TBL] [Abstract][Full Text] [Related]
2. An integrated epigenomic-transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance.
Sun X; Yi J; Yang J; Han Y; Qian X; Liu Y; Li J; Lu B; Zhang J; Pan X; Liu Y; Liang M; Chen E; Liu P; Lu Y
Theranostics; 2021; 11(11):5346-5364. PubMed ID: 33859751
[No Abstract] [Full Text] [Related]
3. Significant associations between driver gene mutations and DNA methylation alterations across many cancer types.
Chen YC; Gotea V; Margolin G; Elnitski L
PLoS Comput Biol; 2017 Nov; 13(11):e1005840. PubMed ID: 29125844
[TBL] [Abstract][Full Text] [Related]
4. Chromatin regulators with tumor suppressor properties and their alterations in human cancers.
Shu XS; Li L; Tao Q
Epigenomics; 2012 Oct; 4(5):537-49. PubMed ID: 23130835
[TBL] [Abstract][Full Text] [Related]
5. Impact of mutations in DNA methylation modification genes on genome-wide methylation landscapes and downstream gene activations in pan-cancer.
Lee CJ; Ahn H; Jeong D; Pak M; Moon JH; Kim S
BMC Med Genomics; 2020 Feb; 13(Suppl 3):27. PubMed ID: 32093698
[TBL] [Abstract][Full Text] [Related]
6. An integrative pan-cancer-wide analysis of epigenetic enzymes reveals universal patterns of epigenomic deregulation in cancer.
Yang Z; Jones A; Widschwendter M; Teschendorff AE
Genome Biol; 2015 Jul; 16(1):140. PubMed ID: 26169266
[TBL] [Abstract][Full Text] [Related]
7. Using epigenomics data to predict gene expression in lung cancer.
Li J; Ching T; Huang S; Garmire LX
BMC Bioinformatics; 2015; 16 Suppl 5(Suppl 5):S10. PubMed ID: 25861082
[TBL] [Abstract][Full Text] [Related]
8. An integrative genomics approach for identifying novel functional consequences of PBRM1 truncated mutations in clear cell renal cell carcinoma (ccRCC).
Wang Y; Guo X; Bray MJ; Ding Z; Zhao Z
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):515. PubMed ID: 27556922
[TBL] [Abstract][Full Text] [Related]
9. Pan-Cancer Landscape of Aberrant DNA Methylation across Human Tumors.
Saghafinia S; Mina M; Riggi N; Hanahan D; Ciriello G
Cell Rep; 2018 Oct; 25(4):1066-1080.e8. PubMed ID: 30355485
[TBL] [Abstract][Full Text] [Related]
10. In-depth genomic data analyses revealed complex transcriptional and epigenetic dysregulations of BRAFV600E in melanoma.
Guo X; Xu Y; Zhao Z
Mol Cancer; 2015 Mar; 14():60. PubMed ID: 25890285
[TBL] [Abstract][Full Text] [Related]
11. Investigation of lipid metabolism dysregulation and the effects on immune microenvironments in pan-cancer using multiple omics data.
Hao Y; Li D; Xu Y; Ouyang J; Wang Y; Zhang Y; Li B; Xie L; Qin G
BMC Bioinformatics; 2019 May; 20(Suppl 7):195. PubMed ID: 31074374
[TBL] [Abstract][Full Text] [Related]
12. Pan-Cancer Analysis Reveals Differential Susceptibility of Bidirectional Gene Promoters to DNA Methylation, Somatic Mutations, and Copy Number Alterations.
Thompson JA; Christensen BC; Marsit CJ
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30081598
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation changes in Down syndrome derived neural iPSCs uncover co-dysregulation of ZNF and HOX3 families of transcription factors.
Laan L; Klar J; Sobol M; Hoeber J; Shahsavani M; Kele M; Fatima A; Zakaria M; Annerén G; Falk A; Schuster J; Dahl N
Clin Epigenetics; 2020 Jan; 12(1):9. PubMed ID: 31915063
[TBL] [Abstract][Full Text] [Related]
14. CTCF loss mediates unique DNA hypermethylation landscapes in human cancers.
Damaschke NA; Gawdzik J; Avilla M; Yang B; Svaren J; Roopra A; Luo JH; Yu YP; Keles S; Jarrard DF
Clin Epigenetics; 2020 Jun; 12(1):80. PubMed ID: 32503656
[TBL] [Abstract][Full Text] [Related]
15. The Genomic Impact of DNA CpG Methylation on Gene Expression; Relationships in Prostate Cancer.
Long MD; Smiraglia DJ; Campbell MJ
Biomolecules; 2017 Feb; 7(1):. PubMed ID: 28216563
[TBL] [Abstract][Full Text] [Related]
16. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
[TBL] [Abstract][Full Text] [Related]
17. Insights from multidimensional analyses of the pan-cancer DNA methylome heterogeneity and the uncanonical CpG-gene associations.
Liu Y; Huang R; Liu Y; Song W; Wang Y; Yang Y; Dong S; Yang X
Int J Cancer; 2018 Dec; 143(11):2814-2827. PubMed ID: 30121964
[TBL] [Abstract][Full Text] [Related]
18. ChARM: Discovery of combinatorial chromatin modification patterns in hepatitis B virus X-transformed mouse liver cancer using association rule mining.
Park SH; Lee SM; Kim YJ; Kim S
BMC Bioinformatics; 2016 Dec; 17(Suppl 16):452. PubMed ID: 28105934
[TBL] [Abstract][Full Text] [Related]
19. Comparative pan-cancer DNA methylation analysis reveals cancer common and specific patterns.
Yang X; Gao L; Zhang S
Brief Bioinform; 2017 Sep; 18(5):761-773. PubMed ID: 27436122
[TBL] [Abstract][Full Text] [Related]
20. Pan-cancer analysis of differential DNA methylation patterns.
Shi M; Tsui SK; Wu H; Wei Y
BMC Med Genomics; 2020 Oct; 13(Suppl 10):154. PubMed ID: 33087120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
